UPDATE 1-Verastem’s blood cancer drug succeeds in late-stage trial

Sept 6 (Reuters) – U.S. drug developer Verastem Incsaid on Wednesday its drug to treat some types of blood cancermet the main goal in a late-stage study by prolonging the timepatients lived without their disease worsening.
The post UPDATE 1-Verastem’s blood cancer drug succeeds in late-stage trial appeared first on RocketNews | Top News Stories From Around the Globe.